Insulet is trading 11.08% up at $164.43 after closing at $148.03 on August 18, 2026; the immediate after-hours trigger remains unclear.

  • Available August 18 coverage identifies no new positive company-specific catalyst.
  • A law-firm notice publicized an August 31 lead-plaintiff deadline for an existing securities lawsuit, citing earlier manufacturing disclosures.
  • The broader market was risk-off, while Insulet moved sharply higher against that backdrop.